Liver fibrosis biomarker assay by LCMS.
Absolute quantification of APO-F in human plasma by MRM.
Peptide selection and library creation using Skyline for MRM.
Reduction of interference by MRM3.
Presence of glycopeptide by MRM and Enhanced product ion scanning.